{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T12:40:09Z","timestamp":1793018409942,"version":"4.5.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000646","name":"Japan Society for the Promotion of Science London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000646","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Photodiagnosis and Photodynamic Therapy"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.pdpdt.2026.105487","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T15:28:17Z","timestamp":1776526097000},"page":"105487","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Enhanced accumulation of protoporphyrin IX via SLC6A6 and SLC36A1 sensitizes cisplatin-resistant cells to 5-aminolevulinic acid-based photodynamic therapy"],"prefix":"10.1016","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4111-2426","authenticated-orcid":false,"given":"Sayo","family":"Horibe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoji","family":"Kawauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Rikitake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pdpdt.2026.105487_bib0001","first-page":"250","article-title":"Photodynamic therapy of cancer: an update","volume":"61","author":"Agostinis","year":"2011","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.pdpdt.2026.105487_bib0002","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.pdpdt.2012.03.002","article-title":"Photodynamic therapy for unresectable cholangiocarcinoma: a comparative effectiveness systematic review and meta-analyses","volume":"9","author":"Leggett","year":"2012","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"10.1016\/j.pdpdt.2026.105487_bib0003","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1111\/j.1476-5381.2009.00620.x","article-title":"Delta-aminolevulinic acid is a substrate for the amino acid transporter SLC36A1 (hPAT1)","volume":"159","author":"Fr\u00f8lund","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pdpdt.2026.105487_bib0004","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/php.12842","article-title":"Protein 4.1R is involved in the transport of 5-aminolevulinic acid by interaction with GATS in MEF cells","volume":"94","author":"Ning","year":"2018","journal-title":"Photochem. Photobiol."},{"key":"10.1016\/j.pdpdt.2026.105487_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065200","article-title":"Homology modeling of human \u03b3-butyric acid transporters and the binding of pro-drugs 5-aminolevulinic acid and methyl aminolevulinic acid used in photodynamic therapy","volume":"8","author":"Baglo","year":"2013","journal-title":"PLOS One"},{"key":"10.1016\/j.pdpdt.2026.105487_bib0006","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/sj.bjc.6601135","article-title":"Selective accumulation of ALA-induced PpIX and photodynamic effect in chemically induced hepatocellular carcinoma","volume":"89","author":"Otake","year":"2003","journal-title":"Br. J. Cancer."},{"key":"10.1016\/j.pdpdt.2026.105487_bib0007","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.intimp.2010.11.029","article-title":"Novel development of 5-aminolevurinic acid (ALA) in cancer diagnoses and therapy","volume":"11","author":"Ishizuka","year":"2011","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.pdpdt.2026.105487_bib0008","first-page":"133","article-title":"Tumor-localizing properties of porphyrins. In vitro studies using the porphyrin precursor, aminolevulinic acid, in free and liposome encapsulated forms","volume":"5","author":"Fukuda","year":"1989","journal-title":"Drug Des. Deliv."},{"key":"10.1016\/j.pdpdt.2026.105487_bib0009","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.bbagen.2019.06.007","article-title":"The biochemical and molecular mechanisms involved in the role of tumor micro-environment stress in development of drug resistance","volume":"1863","author":"Al-Akra","year":"2019","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.pdpdt.2026.105487_bib0010","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.bbrc.2018.11.055","article-title":"CD44v-dependent upregulation of xCT is involved in the acquisition of cisplatin-resistance in human lung cancer A549 cells","volume":"507","author":"Horibe","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.pdpdt.2026.105487_bib0011","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1002\/jps.22501","article-title":"Accumulation and photodynamic activity of chlorin e6 in cisplatin-resistant human lung cancer cells","volume":"100","author":"Horibe","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.pdpdt.2026.105487_bib0012","first-page":"352","article-title":"Metallothionein-IIA gene transcription in cisplatin-resistant cells and its metal-signalling mechanism by Cu(II) ion","volume":"16","author":"Horibe","year":"2005","journal-title":"Biomed. Res. Trace Elements."},{"key":"10.1016\/j.pdpdt.2026.105487_bib0013","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/bjc.1994.244","article-title":"A mechanistic study of cellular photodestruction with 5-aminolaevulinic acid-induced porphyrin","volume":"70","author":"Iinuma","year":"1994","journal-title":"Br. J. Cancer."},{"key":"10.1016\/j.pdpdt.2026.105487_bib0014","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3892\/or.2021.8243","article-title":"Mitochondrial DNA mutations are involved in the acquisition of cisplatin resistance in human lung cancer A549 cells","volume":"47","author":"Horibe","year":"2022","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.pdpdt.2026.105487_bib0015","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1096\/fj.05-3683com","article-title":"Serotonin, L-tryptophan, and tryptamine are effective inhibitors of the amino acid transport system PAT1","volume":"19","author":"Metzner","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.pdpdt.2026.105487_bib0016","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0031-6989(70)80048-0","article-title":"Occurrence of guanidotaurine in mammals: variation of urinary and tissue concentration after guanidotaurine administration","volume":"2","author":"Guidotti","year":"1970","journal-title":"Pharmacol. Res. Commun."},{"key":"10.1016\/j.pdpdt.2026.105487_bib0017","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1208\/s12249-020-01736-7","article-title":"Role of taurine transporter in the retinal uptake of vigabatrin","volume":"21","author":"Police","year":"2020","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.pdpdt.2026.105487_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.pdpdt.2024.104362","article-title":"Efficacy of photodynamic therapy using 5-aminolevulinic acid-induced photosensitization is enhanced in pancreatic cancer cells with acquired drug resistance","volume":"50","author":"Liu","year":"2024","journal-title":"Photodiagnosis Photodyn. Ther."},{"key":"10.1016\/j.pdpdt.2026.105487_bib0019","first-page":"3261","article-title":"Low-density lipoprotein receptor expression is involved in the beneficial effect of photodynamic therapy using talaporfin sodium on gastric cancer cells","volume":"17","author":"Kanda","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.pdpdt.2026.105487_bib0020","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/bjc.2011.12","article-title":"Silencing of ferrochelatase enhances 5-aminolevulinic acid-based fluorescence and photodynamic therapy efficacy","volume":"104","author":"Teng","year":"2011","journal-title":"Br. J. Cancer."},{"key":"10.1016\/j.pdpdt.2026.105487_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.jphotobiol.2020.111963","article-title":"ABCG2 influence on the efficiency of photodynamic therapy in glioblastoma cells","volume":"210","author":"M\u00fcller","year":"2020","journal-title":"J. Photochem. Photobiol. B."}],"container-title":["Photodiagnosis and Photodynamic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100026001547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1572100026001547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T12:25:31Z","timestamp":1793017531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1572100026001547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":21,"alternative-id":["S1572100026001547"],"URL":"https:\/\/doi.org\/10.1016\/j.pdpdt.2026.105487","relation":{},"ISSN":["1572-1000"],"issn-type":[{"value":"1572-1000","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced accumulation of protoporphyrin IX via SLC6A6 and SLC36A1 sensitizes cisplatin-resistant cells to 5-aminolevulinic acid-based photodynamic therapy","name":"articletitle","label":"Article Title"},{"value":"Photodiagnosis and Photodynamic Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pdpdt.2026.105487","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105487"}}